Brain Tumor Stocks List

Brain Tumor Stocks Recent News

Date Stock Title
May 10 CLDX Celldex Therapeutics: Rising High, With Room For Further Growth
May 9 CNSP CNS Pharmaceuticals files for $75M mixed shelf offering
May 9 AMS American Shared Hospital Services Announces Closing of Acquisition of 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island
May 9 YMAB Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
May 9 YMAB Y-mAbs: There's A Ceiling Here Somewhere
May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
May 9 BDRX Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition
May 9 YMAB Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 9 YMAB Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
May 8 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Q1 2024 Earnings Call Transcript
May 8 YMAB Y-mAbs Therapeutics down 18% as Q1 results disappoint
May 8 CLDX Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 7 FENC Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
May 7 YMAB Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics GAAP EPS of -$0.15 in-line, revenue of $19.93M misses by $2.29M
May 7 YMAB Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
May 7 AMS American Shared Hospital Services Announces First Quarter 2024 Earnings Conference Call
May 6 YMAB Y-mAbs Therapeutics Q1 2024 Earnings Preview
May 6 CLDX Celldex GAAP EPS of -$0.56, revenue of $0.16M
Brain Tumor

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors, which start within the brain, and secondary tumors, which have spread from elsewhere, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, problems with vision, vomiting and mental changes. The headache is classically worse in the morning and goes away with vomiting. Other symptoms may include difficulty walking, speaking or with sensations. As the disease progresses, unconsciousness may occur.The cause of most brain tumors is unknown. Uncommon risk factors include inherited neurofibromatosis, exposure to vinyl chloride, Epstein–Barr virus and ionizing radiation. The evidence for mobile phone exposure is not clear. The most common types of primary tumors in adults are meningiomas (usually benign) and astrocytomas such as glioblastomas. In children, the most common type is a malignant medulloblastoma. Diagnosis is usually by medical examination along with computed tomography or magnetic resonance imaging. The result is then often confirmed by a biopsy. Based on the findings, the tumors are divided into different grades of severity.Treatment may include some combination of surgery, radiation therapy and chemotherapy. Anticonvulsant medication may be needed if seizures occur. Dexamethasone and furosemide may be used to decrease swelling around the tumor. Some tumors grow gradually, requiring only monitoring and possibly needing no further intervention. Treatments that use a person's immune system are being studied. Outcome varies considerably depending on the type of tumor and how far it has spread at diagnosis. Glioblastomas usually have poor outcomes, while meningiomas usually have good outcomes. The average five-year survival rate for all brain cancers in the United States is 33%.Secondary, or metastatic, brain tumors are more common than primary brain tumors, with about half of metastases coming from lung cancer. Primary brain tumors occur in around 250,000 people a year globally, making up less than 2% of cancers. In children younger than 15, brain tumors are second only to acute lymphoblastic leukemia as the most common form of cancer. In Australia, the average lifetime economic cost of a case of brain cancer is $1.9 million, the greatest of any type of cancer.

Browse All Tags